
Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company is headquartered in Lakewood, Colorado.
| Revenue (TTM) | $249.72M |
| Gross Profit (TTM) | $160.34M |
| EBITDA | $45.44M |
| Operating Margin | 11.70% |
| Return on Equity | 2.66% |
| Return on Assets | 3.29% |
| Revenue/Share (TTM) | $44.90 |
| Book Value | $33.71 |
| Price-to-Book | 3.14 |
| Price-to-Sales (TTM) | 2.41 |
| EV/Revenue | 2.836 |
| EV/EBITDA | 16.40 |
| Quarterly Earnings Growth (YoY) | -42.40% |
| Quarterly Revenue Growth (YoY) | 1.00% |
| Shares Outstanding | $5.60M |
| Float | $4.96M |
| % Insiders | 5.41% |
| % Institutions | 96.43% |
Volatility is currently expanding

Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript

Mesa Laboratories NASDAQ: MLAB reported first-quarter fiscal 2027 revenue growth of 1%, improved operating margins and continued debt reduction, while newly appointed President and CEO Siddhartha Kadia outlined plans to address fulfillment issues in its Sterilization and Disinfection Control business and accelerate product development in Biopharmaceutical Development.

LAKEWOOD, Colo., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced it will release financial results for its first fiscal quarter (“1Q27”) ended June 30, 2026 following market close on Monday, August 10, 2026. The Company will also hold its first earnings conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts.

Lakewood, Colo., July 06, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2026, to shareholders of record at the close of business on August 31, 2026.

LAKEWOOD, Colo., May 27, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q26”) and fiscal year (“FY26”) ended March 31, 2026 (amounts in thousands).

LAKEWOOD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ended March 31, 2026 at approximately 6:00 A.M. Eastern Time (ET) on Wednesday, May 27, 2026.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on MLAB and any ticker you trade — then tracks every position and per-strategy win rate.